Engel Matthias, Hindie Valerie, Lopez-Garcia Laura A, Stroba Adriana, Schaeffer Francis, Adrian Iris, Imig Jochen, Idrissova Leila, Nastainczyk Wolfgang, Zeuzem Stefan, Alzari Pedro M, Hartmann Rolf W, Piiper Albrecht, Biondi Ricardo M
Research Group PhosphoSites, Department of Pharmaceutical and Medicinal Chemistry, University of Saarland, Saarbrücken, Germany.
EMBO J. 2006 Nov 29;25(23):5469-80. doi: 10.1038/sj.emboj.7601416. Epub 2006 Nov 16.
Organisms rely heavily on protein phosphorylation to transduce intracellular signals. The phosphorylation of a protein often induces conformational changes, which are responsible for triggering downstream cellular events. Protein kinases are themselves frequently regulated by phosphorylation. Recently, we and others proposed the molecular mechanism by which phosphorylation at a hydrophobic motif (HM) regulates the conformation and activity of many members of the AGC group of protein kinases. Here we have developed specific, low molecular weight compounds, which target the HM/PIF-pocket and have the ability to allosterically activate phosphoinositide-dependent protein kinase 1 (PDK1) by modulating the phosphorylation-dependent conformational transition. The mechanism of action of these compounds was characterized by mutagenesis of PDK1, synthesis of compound analogs, interaction-displacement studies and isothermal titration calorimetry experiments. Our results raise the possibility of developing drugs that target the AGC kinases via a novel mode of action and may inspire future rational development of compounds with the ability to modulate phosphorylation-dependent conformational transitions in other proteins.
生物体严重依赖蛋白质磷酸化来转导细胞内信号。蛋白质的磷酸化常常诱导构象变化,这些变化负责触发下游细胞事件。蛋白激酶本身也经常受到磷酸化的调节。最近,我们和其他人提出了一种分子机制,即疏水基序(HM)处的磷酸化如何调节蛋白激酶AGC家族许多成员的构象和活性。在这里,我们开发了特异性的低分子量化合物,这些化合物靶向HM/PIF口袋,并能够通过调节磷酸化依赖性构象转变来变构激活磷酸肌醇依赖性蛋白激酶1(PDK1)。通过对PDK1进行诱变、合成化合物类似物、相互作用置换研究和等温滴定量热实验,对这些化合物的作用机制进行了表征。我们的结果增加了通过一种新的作用方式开发靶向AGC激酶药物的可能性,并可能激发未来合理开发具有调节其他蛋白质磷酸化依赖性构象转变能力的化合物。